Structure Therapeutics Inc. Prepaid Expense and Other Assets, Current
Structure Therapeutics Inc. (GPCR) had Prepaid Expense and Other Assets, Current of $29.37 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-06
- 2026-06-30: Prepaid Expense and Other Assets, Current $29.37M.
- 2026-03-31: Prepaid Expense and Other Assets, Current $32.09M.
- 2025-12-31: Prepaid Expense and Other Assets, Current $24.11M.
- 2025-09-30: Prepaid Expense and Other Assets, Current $14.98M.
| Period end | Prepaid Expense and Other Assets, Current |
|---|---|
| 2026-06-30 | $29.37M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $32.09M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $24.11M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $14.98M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $12.80M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $12.74M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $7.69M 10-K · filed 2026-02-26 |
| 2024-09-30 | $8.37M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $10.50M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $12.91M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $6.29M 10-K · filed 2025-02-27 |
| 2023-09-30 | $4.54M 10-Q · filed 2023-11-17 |
| 2023-06-30 | $3.63M 10-Q/A · filed 2023-11-17 |
| 2023-03-31 | $5.29M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $2.25M 10-K · filed 2024-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |